Aceras BioMedical, LLC is a New York-based company specializing in clinical medicine, healthcare investment, and drug development. Led by Dr. Matthew G. Wyckoff, a licensed physician with extensive experience in the field, the company offers a range of services including due diligence, acquisition, clinical and regulatory development, and corporate development advisory services.
With a strong network in the public and private drug development sectors, both in the United States and abroad, Aceras BioMedical is dedicated to advancing therapeutic programs and building strategic partnerships. Driven by a commitment to innovation and excellence, the company plays a vital role in the healthcare industry, contributing to the development of new treatments and solutions.
Generated from the website